RUN TO KICK exceeds target amount of €1,500,000 four days before kick-off

All proceeds will be used for research into childhood cancer.

RUN TO KICK has passed the €1,500,000 mark. Thanks to the support of 3,200 runners, the goal was reached five days before the starting shot. Never before has such an impressive amount been raised for the fight against brain tumors in children - and it doesn't end here, donations can still be made. "Because every euro brings us closer to the goal of curing every child with cancer."

The battle is not yet fought

This coming Sunday, September 29, the 7th edition of RUN TO KICK will take place in Ter Kamerenbos. Participants will run, walk or cheer to show their solidarity with children and families affected by this terrible disease. This annual event, organized by KickCancer, raises money for groundbreaking research into childhood cancer. This year's theme is brain tumors, the deadliest form of childhood cancer. You can donate via the RUN TO KICK page.

Accreditation and Interviews on 29/09/2024

We invite journalists for a report and/or individual interviews during the seventh edition of RUN TO KICK, please request accreditation in advance via oSérieux: ​
​-Delphine Heenen, founder of KickCancer
​-Children's oncologists ​
​-Families of patients

 

 

 

 

 

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About KickCancer

KickCancer is a young Belgian foundation with a fantastic mission: to cure all children with cancer. Find new treatments, improve existing treatments and kick childhood cancer to the back burner once and for all, so that it will never, ever come back!

To accomplish this mission, KickCancer finances research into more efficient and less toxic treatments in the hope of curing more children and preventing or reducing the long-term side effects of current treatments.

KickCancer is a Belgian foundation with a European calling. Because childhood cancer is so rare, we need to work together at European level to find new treatments. KickCancer finances innovative European research projects that require collaboration across various European institutions on the one hand, and Belgian clinical trials or projects with European collaboration on the other.

KickCancer also represents the interests of children with the government because a better regulatory framework would stimulate the development of new medicines by pharmaceutical companies.

Finally, KickCancer offers young patients and their parents the opportunity to make their voices heard in a structured way through its patient committee. In this way, KickCancer has a direct influence on the quality and orientation of research projects, as well as on the care pathway of young patients and their families.